In this episode of Acquisitions Anonymous,  Heather and Bill discuss the potential acquisition of an e-commerce startup from Australia specializing in health supplements for kidney health. With an asking price of $4.8 million, the business boasts significant revenue and profit figures. However, concerns arise regarding FDA compliance due to the company's health claims, ownership dynamics, and financing challenges. Despite promising aspects like recurring revenue, growth potential, and diverse revenue streams, buyers must carefully consider regulatory risks, ownership issues, and financing options before pursuing the acquisition.Check out the listing here: https://app.acquire.com/startup/P65KROuvdghGALFvyXLb3iZNeH53/U0W784ORYcTi5YRHgsPzAcquire.com is the online marketplace to buy and sell startups.Join 200k+ entrepreneurs closing life-changing deals. Buy and sell startups in as little as 30 days, supported by the best advisors and tech.Thanks to this week's sponsor:Have you ever wished your business’s software was a better fit for your needs?IvyWorks can help. They specialize in building custom solutions for SMB’s complex processes.You forge the vision, and they handle everything else: discovery, design, engineering, creation, and training. They’ve built everything from semi-autonomous, AI-powered roof scanning drones, to mobile apps for managing hundreds of maintenance staff across thousands of properties.They only take a few client partners each year. You’ll be handled personally by founders Callan and Sam, with complete transparency and an open invitation to all development calls.Book a free discovery session, and we’ll make you an actionable project scope document that any software firm can execute. No strings attached.Visit Ivy.Works to learn more. Do you love Acquanon and want to see our smiling faces? Subscribe to our Youtube channel. Do you enjoy our content? Rate our show! Follow us on Twitter @acquanon Learnings about small business acquisitions and operations.